Introduction:

Pain is a complex medical condition, an unpleasant sensation and emotional experience linked to tissue damage which not only affects the physical but also mental well-being of an individual. It is caused due to trauma or tissue damage, and its intensity varies from person to person. Its purpose is to allow the body to react and prevent further tissue damage. Medical approach that draws on disciplines in science and alternative healing is called Pain management. Pain management is one of the branch of medicine which utilizes an inter punitive approach for improving the superiority and easing the suffering of life of persons who are living with the chronic pain. Pain management programs can employ massage therapy, analgesic medications, physical therapy. Minimally invasive procedures and proper use of medications are implemented to achieve pain management goals among individuals.

People are highly prone to suffer from pain owing to chronic diseases such as nerve damage, depression, epilepsy, bone or joint pain, and injuries etc. and rise in elderly population is a major factor contributing towards the growth of the pain management therapeutics market. Increase in R&D investment and rise in outsourcing of pharmaceuticals are expected to fuel the market growth. Increase incidence of accidental and sports injuries, changing lifestyle, early onset of aging, and increasing awareness about of pain management therapeutics are some major factor enhancing the growth of pain management therapeutics market. However, availability of alternative therapies and patent expiration of prescription drugs for treatment of pain are the factor restraining the growth of the pain management therapeutics market. Side-effects caused by certain pain management therapeutics, low adoption in the emerging market inhibit the growth of the target market.

pain management therapeutics market is segmented on the basis of therapeutics, indication, end user and region.

On the basis of therapeutics, to pain management therapeutic market is divided into anticonvulsants, antidepressants, anaesthetics, non-steroidal anti-inflammatory drugs (NSAIDS), opioids, antimigraine agents, and other non-narcotic analgesic. The NSAIDs and opioids segment accounted for the largest share in the pain management therapeutics market. The opioids are expected to register a significant growth rate in the pain management therapeutics market in the coming years. On the basis of indication, the target market is divided into neuropathic pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, and cancer pain. The cancer pain management segment accounted for the largest share in the pain management therapeutics market and is expected to grow at a higher pace during the forecast period. On the basis of end user, the market is divided into hospitals pharmacy, retail pharmacy and online pharmacy. The increasing trend of online purchasing and growing digitalization are significantly contributing towards the growth of online pharmacies over the forecast period.

On the basis of region, the pain management therapeutic market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

North America dominate the pain management therapeutics market in terms of revenue share, owing to presence of appropriate healthcare infrastructure and extensive consumption of high-end pain management drugs by the general population in the region. Europe accounts for the second-highest revenue share to the pain management therapeutics market, owing to increasing use of pain management drugs by the general population followed by Asia Pacific.

Key players in pain management therapeutics market include Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc.

Research Objective and Assumption

• Preface
• Research Objectives
• Study Scope
• Years Considered for the study
• Assumptions
• Abbreviations

Research Typeology

• Research data
• Primary Data
  • Primary Interviews
  • Primary Breakdown
  • Key data from Primary Technologys
  • Key Thickness Insights
• Secondary Data
  • Major Secondary Technologys
  • Secondary Technologys
• Market Estimation
• Top-Down Approach
  • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
• Bottom-Up Approach
  • Approach for estimating market share by Bottom-up Analysis (Demand Side)
• Market Breakdown and Data Triangulation
• Research Assumptions

Market Preview

• Executive Summary
• Key Findings—Global Outlook for medical carts Strategies
  • Key Questions this Study will Answer
  • Market Snippet, By Therapeutics
  • Market Snippet, By Indication
  • Market Snippet, By End User
  • Market Snippet, By Region
• Opportunity Map Analysis
• Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restrains
  • Market Opportunities
  • Market Trends
• DR Impact Analysis
• PEST Analysis
• Porter’s Five Forces Analysis
• Opportunity Orbit
• Market Investment Feasibility Index
• Macroeconomic Factor Analysis

Market Segmentation, By Therapeutics, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Anticonvulsants
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Antidepressants
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Anaesthetics
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Opioids
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Antimigraine Agents
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to
  • n10 Years
• Other Non-Narcotic Analgesic
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Indication, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Neuropathic Pain
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Fibromyalgia
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Chronic Back Pain
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Arthritic Pain
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Migraine
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Post-Operative Pain
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Cancer Pain
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End User, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Hospitals Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Retail Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Online Pharmacy
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (US$ Bn), By Therapeutics, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Indication, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast (US$ Bn), By Therapeutics, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Indication, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • UK
    • France
    • Germany
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast (US$ Bn), By Therapeutics, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Indication, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast (US$ Bn), By Therapeutics, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Indication, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn), By Therapeutics, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Indication, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

Competitive Landscape

• Heat Map Analysis
• Market Presence and Specificity Analysis

Company Profiles

•   Novartis AG
  • Company Overview
  • Technology Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Eli Lilly & Company
  • Company Overview
  • Technology Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Abbott Laboratories
  • Company Overview
  • Technology Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Endo Health Solutions, Inc.
  • Company Overview
  • Technology Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Purdue Pharma L.P
  • Company Overview
  • Technology Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Pfizer, Inc.
  • Company Overview
  • Technology Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• F. Hoffmann La Roche Ltd
  • Company Overview
  • Technology Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Merck & Co. Inc
  • Company Overview
  • Technology Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
•  Johnson & Johnson
  • Company Overview
  • Technology Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• GlaxoSmithKline Plc.
  • Company Overview
  • Technology Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact